Scope Fluidics S.A. is a hub for developing deep-technology projects. Following the sale of the PCR|ONE project to Bio-Rad Laboratories, Scope Fluidics is focused on the development of Bacteromic and on new projects addressing the largest global market needs, where breakthrough technologies can provide exceptional functionality and value. We work in dynamic, young project teams, with the competencies to take a project from the conceptual phase through prototyping, verification, validation, launch, and production.